title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
Stocks That Hit 52-Week Lows On Thursday,20220428T193101,https://www.benzinga.com/markets/options/22/04/26872967/52-weeks-high-and-low-article,EDIT,0.00644,Somewhat-Bearish,-0.185343
"MaxCyte Appoints Cynthia Collins to its Board of Directors - DermTech  ( OTC:DMTKQ ) , Certara  ( NASDAQ:CERT ) ",20241015T120500,https://www.benzinga.com/pressreleases/24/10/g41329104/maxcyte-appoints-cynthia-collins-to-its-board-of-directors,EDIT,0.050894,Neutral,0.034688
"Gene therapy market size to grow by USD 4.61 billion from 2022 to 2027, North America is estimated to contribute 39 ... - PR Newswire",20240318T093600,https://www.prnewswire.com/news-releases/gene-therapy-market-size-to-grow-by-usd-4-61-billion-from-2022-to-2027--north-america-is-estimated-to-contribute-39-to-the-growth-technavio-302090363.html,EDIT,0.033562,Neutral,0.019119
"Gene therapy market size to grow by USD 4,613.9 million from 2022 to 2027 | Growing research in gene therapy for ... - PR Newswire",20231201T073500,https://www.prnewswire.com/news-releases/gene-therapy-market-size-to-grow-by-usd-4-613-9-million-from-2022-to-2027--growing-research-in-gene-therapy-for-cvds-and-orphan-diseases-is-the-major-market-trend--technavio-302002646.html,EDIT,0.048523,Neutral,0.017903
"Gene Therapy Market size to grow by USD 4.61 billion from 2022 to 2027, North America to account for 39% of market ... - PR Newswire",20231103T223500,https://www.prnewswire.com/news-releases/gene-therapy-market-size-to-grow-by-usd-4-61-billion-from-2022-to-2027--north-america-to-account-for-39-of-market-growth--technavio-301976707.html,EDIT,0.074692,Neutral,0.0
"Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial",20220803T141314,https://www.benzinga.com/general/biotech/22/08/28331170/biotech-daily-mercks-two-combo-cancer-trials-miss-main-goal-approval-for-sinovacs-covid-19-shot-f,EDIT,0.098659,Neutral,0.0
"The Daily Biotech Pulse: Veru Seeks Emergency Use Nod For COVID-19 Therapy, Vincerx Cuts Workforce, Moderna Starts Dosing In Flu Vaccine Study",20220607T123117,https://www.benzinga.com/general/biotech/22/06/27583701/the-daily-biotech-pulse-veru-seeks-emergency-use-nod-for-covid-19-therapy-vincerx-cuts-workforce-,EDIT,0.10322,Neutral,0.003115
"Expedia Group, Gartner, Cloudflare, Cardinal Health And Other Big Stocks Moving Higher On Friday - Allogene Therapeutics  ( NASDAQ:ALLO ) , AMC Networks  ( NASDAQ:AMCX ) ",20231103T153022,https://www.benzinga.com/news/23/11/35594375/expedia-group-gartner-cloudflare-cardinal-health-and-other-big-stocks-moving-higher-on-friday,EDIT,0.109206,Bullish,0.575537
"Consolidated Communications, CRISPR Therapeutics And Other Big Stocks Moving Higher On Thursday - Allogene Therapeutics  ( NASDAQ:ALLO ) , AlloVir  ( NASDAQ:ALVR ) ",20230413T143842,https://www.benzinga.com/news/23/04/31789935/consolidated-communications-crispr-therapeutics-and-other-big-stocks-moving-higher-on-thursday,EDIT,0.277433,Neutral,0.0
